Illicit drug markets differ in two key ways: monopolies and duopolies dominate and they suffer from asymmetric information problems, with buyers lacking information about the quality or content of products [41].We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, ana